Brief: ASIT Biotech announces the initiation of a phase 2a clinical study of its second product candidate hdm-ASIT+(TM) for House Dust Mite Rhinitis

European Medical Solutions SA

22/09/2016 17:27

Sept 22 (Reuters) - ASIT Biotech SA  ASIT.BR : 
    * announces the initiation of a phase 2a clinical study of 
its second product candidate hdm-ASIT+(TM)for House Dust Mite 
Rhinitis 
 
Source text for Eikon:  ID:nBw3CLlj2a  
Further company coverage:  ASIT.BR  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))